Icotinib hydrochloride enhances the effect of radiotherapy by affecting DNA repair in colorectal cancer cells

  • Authors:
    • Hong Ma
    • Jianping Bi
    • Tao Liu
    • Yang Ke
    • Sheng Zhang
    • Tao Zhang
  • View Affiliations

  • Published online on: December 30, 2014     https://doi.org/10.3892/or.2014.3699
  • Pages: 1161-1170
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The aim of the present study was to explore the efficacy and mechanism of the radiosensitisation of icotinib hydrochloride (IH), a novel oral epidermal growth factor receptor-tyrosine kinase activity inhibitor, by evaluating the changes in tumour cell double-strand breaks (DSBs) repair, cell cycle and apoptosis following a combination of IH and radiotherapy (RT) in human colorectal adenocarcinoma cell lines. The HT29 and HCT116 human CRC cell lines were treated with IH and/or radiation. Effects on cell viability and cell cycle progression were measured by MTT, a clonogenic survival assay, and flow cytometry. Immunofluorescent staining and western blot analysis were applied to detect the expression of γ-H2AX and 53BP1 in the different treatment groups. Finally, the in vivo effect on the growth of CRC xenografts was assessed in athymic nude mice. IH inhibited the proliferation and enhanced the radiosensitivity in HT29 and HCT116 CRC cells lines. IH combined with radiation increased cell cycle arrest in the G2/M phase compared to the other treatments in the HT29 cell line (P<0.05). Similarly, cell cycle arrest occurred in the HCT116 cell line, although this increase did not result in significant differences in the RT group (P>0.05). IH combined with radiation significantly inhibited the expression of γ-H2AX and 53BP1 based on results of immunofluorescent staining and western blot analysis. In vivo, IH plus radiation significantly inhibited the tumour growth compared to either agent independently. In conclusion, IH significantly increased the radiosensitivity of HT29 and HCT116 cells in vitro and in vivo. Radiation combined with EGFR blockade inhibited tumour proliferation, increased apoptosis, prolonged G2/M arrest and significantly enhanced DNA injury in colorectal cancer. These data support the clinical trials of biologically targeted and conventional therapies in the treatment of cancer.
View Figures
View References

Related Articles

Journal Cover

March-2015
Volume 33 Issue 3

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Ma H, Bi J, Liu T, Ke Y, Zhang S and Zhang T: Icotinib hydrochloride enhances the effect of radiotherapy by affecting DNA repair in colorectal cancer cells. Oncol Rep 33: 1161-1170, 2015
APA
Ma, H., Bi, J., Liu, T., Ke, Y., Zhang, S., & Zhang, T. (2015). Icotinib hydrochloride enhances the effect of radiotherapy by affecting DNA repair in colorectal cancer cells. Oncology Reports, 33, 1161-1170. https://doi.org/10.3892/or.2014.3699
MLA
Ma, H., Bi, J., Liu, T., Ke, Y., Zhang, S., Zhang, T."Icotinib hydrochloride enhances the effect of radiotherapy by affecting DNA repair in colorectal cancer cells". Oncology Reports 33.3 (2015): 1161-1170.
Chicago
Ma, H., Bi, J., Liu, T., Ke, Y., Zhang, S., Zhang, T."Icotinib hydrochloride enhances the effect of radiotherapy by affecting DNA repair in colorectal cancer cells". Oncology Reports 33, no. 3 (2015): 1161-1170. https://doi.org/10.3892/or.2014.3699